20.35
price up icon4.41%   0.86
after-market Handel nachbörslich: 20.58 0.23 +1.13%
loading

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
Oct 27, 2025

Tonix Pharmaceuticals Holding Corp. stock trend forecastTrade Entry Report & Reliable Price Breakout Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to recover losses in Tonix Pharmaceuticals Holding Corp. stockTrade Exit Report & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.July 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals (TNXP) Unveils Positive Trial Results for Tonmya - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix PharmaceuticalsPrelim Q3 net revenue from product sales $3.3 millionSEC filing - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix (Nasdaq: TNXP) reports Phase 3 Tonmya fibromyalgia data: Week 14 pain reduction - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock a safe haven assetEarnings Overview Summary & Low Risk High Reward Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock trading at a premium valuation2025 Institutional Moves & Weekly Breakout Watchlists - newser.com

Oct 27, 2025
pulisher
Oct 24, 2025

First patient dosed in MGH-Led FOCUS study of Tonix’s investigational intranasal Oxytocin product - Proactive financial news

Oct 24, 2025
pulisher
Oct 24, 2025

Understanding Momentum Shifts in (TNXP) - news.stocktradersdaily.com

Oct 24, 2025
pulisher
Oct 23, 2025

Tonix: Assessing Tonmya's Commercial Potential Ahead Of Q4 2025 Launch - Seeking Alpha

Oct 23, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals (TNXP) Launches New Study for Rare Endocri - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Can Tonix Pharmaceuticals Holding Corp. recover in the next quarterPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals Holding Corp. stock daily chart insightsTrade Risk Report & Daily Price Action Insights - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals Announces Poster Presentation of Tonmya™ at 2025 American College of Rheumatology Convergence - Quiver Quantitative

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharma (Nasdaq: TNXP) to present Tonmya fibromyalgia data at ACR 2025 on Oct 27 - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

What analysts say about Tonix Pharmaceuticals Holding Corp stockSmall Cap Stock Opportunities & Small Investment Trading Growth - earlytimes.in

Oct 21, 2025
pulisher
Oct 20, 2025

Analyzing Tonix Pharmaceuticals Holding Corp. with risk reward ratio chartsMarket Volume Summary & AI Driven Stock Movement Reports - newser.com

Oct 20, 2025
$37.26
price up icon 0.00%
$93.08
price up icon 1.97%
$29.03
price down icon 2.88%
$106.05
price up icon 0.37%
biotechnology ONC
$315.43
price up icon 1.49%
$164.02
price up icon 2.73%
Kapitalisierung:     |  Volumen (24h):